Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Escherichia Coli Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00328380
What this trial is testing

Prevention of Travelers' Diarrhea in Subjects Traveling Outside the U.S.

Who this might be right for
Diarrhea
Bausch Health Americas, Inc. 660
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808103
What this trial is testing

Safety and Efficacy of EcoActive on Intestinal Adherent Invasive E. Coli in Patients With Inactive Crohn's Disease

Who this might be right for
Crohn Disease
Intralytix, Inc. 30
Not applicableStudy completedNCT01961206
What this trial is testing

Community-Onset Bacteremia Due to ESBL Producing E.Coli or K.Pneumoniae in China: Prevalence, Risk Factors and Prognosis

Who this might be right for
Community Acquired Infection
Jian-cang Zhou M.D. 960
Large-scale testing (Phase 3)Study completedNCT01410916
What this trial is testing

Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)

Who this might be right for
Shiga-like Toxin-producing Escherichia Coli
Alexion Pharmaceuticals, Inc. 198
Post-approval studies (Phase 4)Study completedNCT02584543
What this trial is testing

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)

Who this might be right for
Hepatitis EHepatitis B
Xiamen Innovax Biotech Co., Ltd 602
Post-approval studies (Phase 4)Looking for participantsNCT07668271
What this trial is testing

Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

Who this might be right for
Infection by Human Papilloma Virus
Xiamen Innovax Biotech Co., Ltd 720
Not applicableStudy completedNCT02390232
What this trial is testing

Prospective Cohort Assessing the Role of the Genotoxin Colibactin From Escherichia Coli B2 in the Genesis of NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
University Hospital, Toulouse 176
Testing effectiveness (Phase 2)Study completedNCT05178134
What this trial is testing

Bridging Study to Assess the New Formulation of ETVAX

Who this might be right for
Healty VolunteersPreventable Disease, Vaccine
Scandinavian Biopharma AB 280
Not applicableUnknownNCT03800147
What this trial is testing

Effects of Nutritional Fat on the Growth of Intestinal E. Coli

Who this might be right for
Escherichia Coli Infections
University of Zurich 40
Not applicableStudy completedNCT07332078
What this trial is testing

Meatsafe Food Storage and Diarrhea Prevention Trial in Urban Bangladesh

Who this might be right for
Diarrhea
University of California, Berkeley 290
Testing effectiveness (Phase 2)UnknownNCT02710851
What this trial is testing

Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 640
Early research (Phase 1)Study completedNCT03404674
What this trial is testing

Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC)

Who this might be right for
Diarrhea
PATH 50
Large-scale testing (Phase 3)Study completedNCT00742469
What this trial is testing

Rifaximin for Prevention of Travellers' Diarrhea

Who this might be right for
Diarrhea
Bausch Health Americas, Inc. 210
Not applicableLooking for participantsNCT05017766
What this trial is testing

NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria

Who this might be right for
Antimicrobial Resistance (AMR)
University Hospital, Basel, Switzerland 8,000
Early research (Phase 1)Study completedNCT02405520
What this trial is testing

Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Who this might be right for
Condylomata Acuminata
Jun Zhang 145
Not applicableWithdrawnNCT06482151
What this trial is testing

Evaluation of the Prevalence of E. Coli O Serotypes in Paediatric Population With Recurrent Urinary Tract Infection

Who this might be right for
Urinary Tract Infections
PENTA Foundation
Early research (Phase 1)Study completedNCT03813940
What this trial is testing

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 24
Testing effectiveness (Phase 2)Looking for participantsNCT06938867
What this trial is testing

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Who this might be right for
E Coli InfectionsAllogenic Transplant Patients
SNIPR Biome Aps. 24
Not applicableUnknownNCT04076436
What this trial is testing

Efficacy of Intravenous Fosfomycin in the Treatment of Complicated Urinary in Real-life Conditions.

Who this might be right for
Complicated Urinary Tract Infection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 400
Not applicableEnded earlyNCT05613322
What this trial is testing

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia

Who this might be right for
Bacteremia Sepsis
Resistell AG 246
Next Page